Personalised therapeutic management of epileptic patients guided by pathway-driven breath metabolomics

BACKGROUND: Therapeutic management of epilepsy remains a challenge, since optimal systemic antiseizure medication (ASM) concentrations do not always correlate with improved clinical outcome and minimal side effects. We tested the feasibility of noninvasive real-time breath metabolomics as an extensi...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Kapil Dev, Osswald, Martin, Ziesenitz, Victoria C., Awchi, Mo, Usemann, Jakob, Imbach, Lukas L., Kohler, Malcolm, García-Gómez, Diego, van den Anker, Johannes, Frey, Urs, Datta, Alexandre N., Sinues, Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053280/
https://www.ncbi.nlm.nih.gov/pubmed/35602217
http://dx.doi.org/10.1038/s43856-021-00021-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053280/
https://www.ncbi.nlm.nih.gov/pubmed/35602217
http://dx.doi.org/10.1038/s43856-021-00021-3

Ejemplares similares